Average Co-Inventor Count = 5.87
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Fremont Inc. (26 from 78 patents)
2. Pfizer Corporation (21 from 4,455 patents)
3. Abgenix, Inc. (7 from 32 patents)
4. Amgen Inc. (3 from 1,974 patents)
5. Schering Corporation (2 from 1,829 patents)
6. Other (1 from 832,843 patents)
7. Pfizer Products Inc. (47 patents)
34 patents:
1. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
2. 9963508 - Human monoclonal antibodies to CTLA-4
3. 9234041 - Antibodies to insulin-like growth factor I receptor
4. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
5. 9085624 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
6. 9073998 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
7. 9062113 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
8. 8883984 - Human monoclonal antibodies to CTLA-4
9. 8642037 - Antibodies to insulin-like growth factor I receptor
10. 8491895 - Methods of treating cancer with human monoclonal antibodies to CTLA-4
11. 8409578 - Methods for treating bone loss with antibodies to OPGL
12. 8388971 - Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
13. 8143379 - Human monoclonal antibodies to CTLA-4
14. 8058418 - Polynucleotides encoding heavy and light chains of antibodies to OPGL
15. 7982024 - Antibodies to insulin-like growth factor I receptor